secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2024-07-22T23:59:59+00:00
Accession:  0001193125-24-181938
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jazz reprices $2.7B term loan; margin cut 75 bps to 2.25%+SOFR
--------------------------------------------------------------

- Entered Amendment No. 2 to Credit Agreement; Tranche B-2 Dollar Term Loans replace Tranche B-1 at same $2,707,000,000 outstanding.
- Interest margin reduced 75 basis points: new rates are 2.25% (Term SOFR) and 1.25% (prime) vs prior margins.
- Maturity unchanged at May 5, 2028; quarterly amortization of 0.2863% of initial principal; SOFR floor of 0.50% remains.
- Proceeds from new $289.6M additional borrowing used to repay non-converted Tranche B-1 loans; structure includes converting and non-converting lenders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524181938/0001193125-24-181938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524181938/d813284d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-181938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer